Crossmark Global Holdings, Inc. Charles River Laboratories International, Inc. Transaction History
Crossmark Global Holdings, Inc.
- $5.5 Billion
- Q1 2025
A detailed history of Crossmark Global Holdings, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 4,856 shares of CRL stock, worth $685,667. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,856
Previous 4,929
1.48%
Holding current value
$685,667
Previous $910,000
19.78%
% of portfolio
0.01%
Previous 0.02%
Shares
31 transactions
Others Institutions Holding CRL
# of Institutions
648Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$862 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$718 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$605 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$338 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$275 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.18B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...